Healthcare provider profile · identity verified

Robert Michael Levy, MD

Family Practice · KANNAPOLIS, NC · NPI 1659577179

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	609	150
Amlodipine Besylate	Amlodipine Besylate	430	105
Levothyroxine Sodium	Levothyroxine Sodium	425	87
Lisinopril	Lisinopril	414	89
Omeprazole	Omeprazole	414	113
Rosuvastatin Calcium	Rosuvastatin Calcium	366	89
Losartan Potassium	Losartan Potassium	328	77
Gabapentin	Gabapentin	264	73
Hydrochlorothiazide	Hydrochlorothiazide	249	55
Jardiance	Empagliflozin	234	40
Pravastatin Sodium	Pravastatin Sodium	224	47
Trazodone Hcl	Trazodone Hcl	222	60
Eliquis	Apixaban	212	35
Sertraline Hcl	Sertraline Hcl	204	50
Metformin Hcl Er	Metformin Hcl	189	41
Duloxetine Hcl	Duloxetine Hcl	181	29
Metoprolol Succinate	Metoprolol Succinate	179	47
Escitalopram Oxalate	Escitalopram Oxalate	174	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	169	37
Buspirone Hcl	Buspirone Hcl	166	26
Alprazolam	Alprazolam	162	26
Spironolactone	Spironolactone	162	38
Albuterol Sulfate Hfa	Albuterol Sulfate	159	37
Tramadol Hcl	Tramadol Hcl	158	34
Tamsulosin Hcl	Tamsulosin Hcl	153	41
Metoprolol Tartrate	Metoprolol Tartrate	148	43
Trulicity	Dulaglutide	145	24
Pioglitazone Hcl	Pioglitazone Hcl	143	31
Simvastatin	Simvastatin	142	38
Tizanidine Hcl	Tizanidine Hcl	141	41
Furosemide	Furosemide	132	35
Montelukast Sodium	Montelukast Sodium	127	32
Clonazepam	Clonazepam	126	15
Pantoprazole Sodium	Pantoprazole Sodium	121	26
Clopidogrel	Clopidogrel Bisulfate	116	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	116	31
Meloxicam	Meloxicam	113	33
Lorazepam	Lorazepam	105	18
Venlafaxine Hcl Er	Venlafaxine Hcl	105	17
Fluticasone Propionate	Fluticasone Propionate	98	36
Allopurinol	Allopurinol	97	26
Valsartan	Valsartan	91	27
Mounjaro	Tirzepatide	85	15
Metformin Hcl	Metformin Hcl	83	16
Mirtazapine	Mirtazapine	82	19
Triamcinolone Acetonide	Triamcinolone Acetonide	78	30
Alendronate Sodium	Alendronate Sodium	75	18
Ozempic	Semaglutide	75	suppressed
Potassium Chloride	Potassium Chloride	75	15
Citalopram Hbr	Citalopram Hydrobromide	74	17
Xarelto	Rivaroxaban	73	11
Finasteride	Finasteride	69	19
Symbicort	Budesonide/Formoterol Fumarate	69	15
Bupropion Xl	Bupropion Hcl	68	16
Prednisone	Prednisone	67	44
Zolpidem Tartrate	Zolpidem Tartrate	66	suppressed
Carvedilol	Carvedilol	62	17
Celecoxib	Celecoxib	61	21
Esomeprazole Magnesium	Esomeprazole Magnesium	61	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	57	12
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Pregabalin	Pregabalin	51	11
Warfarin Sodium	Warfarin Sodium	50	11
Famotidine	Famotidine	46	13
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Topiramate	Topiramate	45	12
Donepezil Hcl	Donepezil Hcl	44	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	43	suppressed
Doxepin Hcl	Doxepin Hcl	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	37
Combivent Respimat	Ipratropium/Albuterol Sulfate	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	13
Ventolin Hfa	Albuterol Sulfate	37	11
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Temazepam	Temazepam	35	suppressed
Dexlansoprazole Dr	Dexlansoprazole	33	suppressed
Spiriva Respimat	Tiotropium Bromide	33	suppressed
Testosterone	Testosterone	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Torsemide	Torsemide	29	suppressed
Tresiba Flextouch U-200	Insulin Degludec	29	suppressed
Azithromycin	Azithromycin	28	16
Memantine Hcl	Memantine Hcl	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	suppressed
Baclofen	Baclofen	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	25
Naproxen	Naproxen	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Nystatin	Nystatin	21	14
Valacyclovir	Valacyclovir Hcl	21	12
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Mupirocin	Mupirocin	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Lovastatin	Lovastatin	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Cephalexin	Cephalexin	15	12
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lactulose	Lactulose	15	suppressed
Linzess	Linaclotide	15	suppressed
Nexium	Esomeprazole Magnesium	15	suppressed
Nitroglycerin	Nitroglycerin	15	14
Fesoterodine Fumarate Er	Fesoterodine Fumarate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methimazole	Methimazole	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Novolog Flexpen	Insulin Aspart	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Belsomra	Suvorexant	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Norgestimate-Ethinyl Estradiol	Norgestimate-Ethinyl Estradiol	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error